title: Acarbose vs metformin for new-onset type 2 diabetes.
authors.affiliation: Oncological Endocrinology, AO Città della Salute e della Scienza-Molinette, Via Genova, 3, I-10137 Turin, Italy. Electronic address: mgallo4@cittadellasalute.to.it.
authors.forename: Marco
authors.initials: M
authors.lastname: Gallo
authors.affiliation: Diabetes Center, A.S.S. 1 Triestina, Trieste, Italy.
authors.forename: Riccardo
authors.initials: R
authors.lastname: Candido
authors.affiliation: Ligurian Health Agency, Genoa, Italy.
authors.forename: Alberto
authors.initials: A
authors.lastname: De Micheli
authors.affiliation: Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy.
authors.forename: Katherine
authors.initials: K
authors.lastname: Esposito
authors.affiliation: Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy.
authors.forename: Sandro
authors.initials: S
authors.lastname: Gentile
authors.affiliation: Insititut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain.
authors.forename: Antonio
authors.initials: A
authors.lastname: Ceriello
mesh_terms: D020909:Acarbose / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008687:Metformin / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D008687:Metformin; D020909:Acarbose